Article

The Economics of Vaccines

Frank A. Sloan

in The Oxford Handbook of the Economics of the Biopharmaceutical Industry

Published in print April 2012 | ISBN: 9780199742998
Published online September 2012 | | DOI: http://dx.doi.org/10.1093/oxfordhb/9780199742998.013.0017

Series: Oxford Handbooks

 The Economics of Vaccines

More Like This

Show all results sharing these subjects:

  • Economics
  • Health, Education, and Welfare
  • Econometric and Statistical Methods and Methodology: General

GO

Show Summary Details

Preview

This article discusses preventive vaccines, focusing on features that differentiate these vaccines from other biopharmaceuticals. The external costs of infectious diseases imply external benefits from effective vaccines, and this has motivated public mandates, purchasing, and subsidies to demand for vaccines in most countries and government subsidies to supply for particular products, such as Project Bioshield in the United States. The article reviews these issues and then discusses factors that have contributed to the existence of few or sole suppliers of individual vaccines in the United States and possible policy responses.

Keywords: preventive vaccines; infectious disease; Project Bioshield; biopharmaceuticals

Article.  12194 words. 

Subjects: Economics ; Health, Education, and Welfare ; Econometric and Statistical Methods and Methodology: General

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.